REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,386 | -88.8% | 45,578 | -59.7% | 0.00% | – |
| Q3 2022 | $57,000 | -32.9% | 113,155 | +15.3% | 0.00% | – |
| Q2 2022 | $85,000 | -78.0% | 98,120 | -36.1% | 0.00% | – |
| Q1 2022 | $386,000 | -82.3% | 153,466 | -81.8% | 0.00% | – |
| Q4 2021 | $2,180,000 | -15.8% | 845,140 | +49.5% | 0.00% | – |
| Q3 2021 | $2,588,000 | -49.9% | 565,204 | -24.7% | 0.00% | – |
| Q2 2021 | $5,166,000 | -12.3% | 750,791 | -6.7% | 0.00% | – |
| Q1 2021 | $5,891,000 | +14.7% | 804,703 | +26.6% | 0.00% | – |
| Q4 2020 | $5,136,000 | +62.9% | 635,556 | +105.9% | 0.00% | – |
| Q3 2020 | $3,153,000 | +155.5% | 308,602 | +67.7% | 0.00% | – |
| Q2 2020 | $1,234,000 | +681.0% | 183,984 | +430.4% | 0.00% | – |
| Q1 2020 | $158,000 | -65.3% | 34,691 | -53.6% | 0.00% | – |
| Q4 2019 | $455,000 | -31.1% | 74,833 | -20.1% | 0.00% | – |
| Q3 2019 | $660,000 | +205.6% | 93,716 | +181.4% | 0.00% | – |
| Q2 2019 | $216,000 | +75.6% | 33,300 | +125.0% | 0.00% | – |
| Q1 2019 | $123,000 | +75.7% | 14,800 | +17.5% | 0.00% | – |
| Q4 2018 | $70,000 | -51.4% | 12,600 | -22.7% | 0.00% | – |
| Q3 2018 | $144,000 | -6.5% | 16,300 | -9.9% | 0.00% | – |
| Q2 2018 | $154,000 | – | 18,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |